An accessible industry overview of the science, clinical workflow, commercialization challenges, and data foundation behind targeted radiopharmaceuticals By Charlie Fetsko, 20/15 Visioneer Intern Overview Radioligand therapy (RLT) is a rapidly advancing form of precision cancer treatment that uses a tumor-seeking molecule to carry radiation directly to cancer cells. Unlike external-beam radiation therapy, which directs radiation into the body from an external source, RLT travels through the...

By Kelly Cycon, PhD | 20/15 Visioneers If you’ve ever watched a term sheet slow down over a question that had nothing to do with your science, this is for you. Every founder braces for the funding valley of death, and an entire ecosystem of grants, accelerators, and tech‑transfer programs exists to pull them across it. Almost no one warns you about the second valley: the operational gap that gets exposed at diligence, IND, and partnership; where fundable science stalls, not because the work...

By 20/15 Visioneers May 2026 Executive Summary Clinical development is at an inflection point. Since the adoption of Electronic Data Capture, the industry has focused primarily on execution efficiency, optimizing CROs, site networks, and operational workflows. That paradigm is giving way to something more fundamental: designing better trials before they begin and ultimately getting much-needed medicines and therapies to patients faster. The convergence of Artificial Intelligence,...